According to the statistics of dolphin stock data, as of the closing, the stock price of Guoxin Health was 16.58 yuan, with a rise and fall of -3.38%, a turnover rate of 1.05%, and a turnover of 159 million yuan throughout the day.
01. Funding Interpretation
Today, the stock's main funds inflowed 46.69 million yuan, outflowed 89.91 million yuan, and net outflowed 43.23 million yuan, of which the net outflow of 23.71 million yuan was 19.52 million yuan, the net outflow of large orders was 19.35 million yuan, and the net inflow of small orders was 23.88 million yuan.
02. Chip Analysis
Chip Pattern: The current chip pattern of this stock is a dense pattern. In the past 30 days, the chip density has increased from 81% to 82%. During the same period, the stock price rose from 15.20 yuan to 16.58 yuan, an increase of 9.08%.
chip profit and loss: Overall profit chips account for 34.03%, with an average loss of 1.46%, of which 5% of the light profit chips account for 5%, 0% of the heavy profit chips account for 0%, 0% of the heavy trapped chips account for 8%, and 8% of the light trapped chips.
chip cost: main cost is 16.55 yuan, the average cost is 16.90 yuan, and the chip intensive cost is 17.28 yuan, of which 90% of the chips have the highest price of 19.16 yuan, the lowest price is 15.07 yuan, the concentration is 88.05%, the profit ratio of 29.26%, the highest price of 70% chips is 17.72 yuan, the lowest price is 15.55 yuan, the concentration is 93.48%, and the profit ratio is 19.18%.
03. Trading Analysis
Dolphin Stock APP Trading Line Trend Analysis: The trend is in a downward trend, and the short-term trend is weaker than the market. The negative line of broke through, and the volume fell sharply, and the strength of short continued to be released.
04. Texture Analysis
Company's main business: The company is mainly engaged in the health protection service industry, and its main business covers five major areas: medical insurance fund comprehensive management services, health and medical big data services, medical welfare management services (PBM), commercial health insurance third-party services (TPA), and medical artificial intelligence services.
As of September 30, 2019, Guoxin Health 's operating income was 53.662 million yuan, and the net profit attributable to the parent company's shareholders was -146 million yuan, a year-on-year decrease of 29.11%.
No institutions have conducted research on Guoxin Health in the past three months, and the stock has received less attention from institutions.
Click to download the Dolphin Stock APP, and the smart market-oriented free experience for life
Disclaimer: The information provided on this page is for investors' reference only and does not constitute any investment advice.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-